Vaibhav Agrawal

18PUBLICATIONS
30CO-AUTHORS
Haematological tumoursHaematologyPsychological methodology, design and analysisTransplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 23, 2026
Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia.

|Sep 10, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden.

Jose Tinajero, Kim Nguyen, Dat Ngo

|Sep 01, 2025
The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemia.

Hoda Pourhassan, Jose Tinajero, Huiyan Ma

|Jun 10, 2025
The integration of blinatumomab consolidation in the CALGB 10403 regimen for adults with B-cell precursor acute lymphoblastic leukaemia in measurable residual disease-negative remission.

Jose Tinajero, Dat Ngo, Maria Motta

|Apr 10, 2025
Hypomethylating agent and venetoclax are effective salvage therapies in relapsed/refractory early T-cell precursor acute lymphoblastic leukaemia.

Vaibhav Agrawal, Shukaib Arslan, Hoda Pourhassan

|Nov 06, 2024
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high-grade hepatotoxicity without adversely impacting outcomes.

Jose Tinajero, Sharon Xu, Dat Ngo

Pageof 3

Frequent Collaborators

11 joint publications

Hoda Pourhassan

10 joint publications

Ibrahim Aldoss

9 joint publications

Paul Koller

7 joint publications

Vinod Pullarkat